These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

197 related items for PubMed ID: 12842303

  • 1. An open trial of bupropion for the treatment of adults with attention-deficit/hyperactivity disorder and bipolar disorder.
    Wilens TE, Prince JB, Spencer T, Van Patten SL, Doyle R, Girard K, Hammerness P, Goldman S, Brown S, Biederman J.
    Biol Psychiatry; 2003 Jul 01; 54(1):9-16. PubMed ID: 12842303
    [Abstract] [Full Text] [Related]

  • 2. A controlled clinical trial of bupropion for attention deficit hyperactivity disorder in adults.
    Wilens TE, Spencer TJ, Biederman J, Girard K, Doyle R, Prince J, Polisner D, Solhkhah R, Comeau S, Monuteaux MC, Parekh A.
    Am J Psychiatry; 2001 Feb 01; 158(2):282-8. PubMed ID: 11156812
    [Abstract] [Full Text] [Related]

  • 3. Atomoxetine as an adjunct therapy in the treatment of co-morbid attention-deficit/hyperactivity disorder in children and adolescents with bipolar I or II disorder.
    Chang K, Nayar D, Howe M, Rana M.
    J Child Adolesc Psychopharmacol; 2009 Oct 01; 19(5):547-51. PubMed ID: 19877979
    [Abstract] [Full Text] [Related]

  • 4. Bupropion XL in adults with attention-deficit/hyperactivity disorder: a randomized, placebo-controlled study.
    Wilens TE, Haight BR, Horrigan JP, Hudziak JJ, Rosenthal NE, Connor DF, Hampton KD, Richard NE, Modell JG.
    Biol Psychiatry; 2005 Apr 01; 57(7):793-801. PubMed ID: 15820237
    [Abstract] [Full Text] [Related]

  • 5. Bupropion SR for the treatment of substance-abusing outpatient adolescents with attention-deficit/hyperactivity disorder and mood disorders.
    Solhkhah R, Wilens TE, Daly J, Prince JB, Van Patten SL, Biederman J.
    J Child Adolesc Psychopharmacol; 2005 Oct 01; 15(5):777-86. PubMed ID: 16262594
    [Abstract] [Full Text] [Related]

  • 6. Bupropion SR vs. methylphenidate vs. placebo for attention deficit hyperactivity disorder in adults.
    Kuperman S, Perry PJ, Gaffney GR, Lund BC, Bever-Stille KA, Arndt S, Holman TL, Moser DJ, Paulsen JS.
    Ann Clin Psychiatry; 2001 Sep 01; 13(3):129-34. PubMed ID: 11791949
    [Abstract] [Full Text] [Related]

  • 7. Bupropion sustained release in adolescents with comorbid attention-deficit/hyperactivity disorder and depression.
    Daviss WB, Bentivoglio P, Racusin R, Brown KM, Bostic JQ, Wiley L.
    J Am Acad Child Adolesc Psychiatry; 2001 Mar 01; 40(3):307-14. PubMed ID: 11288772
    [Abstract] [Full Text] [Related]

  • 8. Bupropion versus methylphenidate in the treatment of children with attention-deficit/hyperactivity disorder: randomized double-blind study.
    Jafarinia M, Mohammadi MR, Modabbernia A, Ashrafi M, Khajavi D, Tabrizi M, Yadegari N, Akhondzadeh S.
    Hum Psychopharmacol; 2012 Jul 01; 27(4):411-8. PubMed ID: 22806822
    [Abstract] [Full Text] [Related]

  • 9. A Systematic Review of the Use of Bupropion for Attention-Deficit/Hyperactivity Disorder in Children and Adolescents.
    Ng QX.
    J Child Adolesc Psychopharmacol; 2017 Mar 01; 27(2):112-116. PubMed ID: 27813651
    [Abstract] [Full Text] [Related]

  • 10. Translating Attention-Deficit/Hyperactivity Disorder Rating Scale-5 and Weiss Functional Impairment Rating Scale-Parent Effectiveness Scores into Clinical Global Impressions Clinical Significance Levels in Four Randomized Clinical Trials of SPN-812 (Viloxazine Extended-Release) in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder.
    Nasser A, Kosheleff AR, Hull JT, Liranso T, Qin P, Busse GD, O'Neal W, Fava M, Faraone SV, Rubin J.
    J Child Adolesc Psychopharmacol; 2021 Apr 01; 31(3):214-226. PubMed ID: 33600233
    [Abstract] [Full Text] [Related]

  • 11. An Open Trial of Sustained Release Bupropion for Attention-Deficit/Hyperactivity Disorder in Adults with ADHD plus Substance Use Disorders.
    Wilens TE, Prince JB, Waxmonsky J, Doyle R, Spencer T, Martelon M, Evans M.
    J ADHD Relat Disord; 2010 Apr 01; 1(3):25-35. PubMed ID: 22500195
    [Abstract] [Full Text] [Related]

  • 12. An open trial of bupropion for ADHD in adolescents with substance use disorders and conduct disorder.
    Riggs PD, Leon SL, Mikulich SK, Pottle LC.
    J Am Acad Child Adolesc Psychiatry; 1998 Dec 01; 37(12):1271-8. PubMed ID: 9847499
    [Abstract] [Full Text] [Related]

  • 13. Venlafaxine in adults with attention-deficit/hyperactivity disorder: an open clinical trial.
    Findling RL, Schwartz MA, Flannery DJ, Manos MJ.
    J Clin Psychiatry; 1996 May 01; 57(5):184-9. PubMed ID: 8626348
    [Abstract] [Full Text] [Related]

  • 14. Treatment of methadone-maintained patients with adult ADHD: double-blind comparison of methylphenidate, bupropion and placebo.
    Levin FR, Evans SM, Brooks DJ, Kalbag AS, Garawi F, Nunes EV.
    Drug Alcohol Depend; 2006 Feb 01; 81(2):137-48. PubMed ID: 16102908
    [Abstract] [Full Text] [Related]

  • 15. Extended-release bupropion: an antidepressant with a broad spectrum of therapeutic activity?
    Clayton AH.
    Expert Opin Pharmacother; 2007 Mar 01; 8(4):457-66. PubMed ID: 17309340
    [Abstract] [Full Text] [Related]

  • 16. Randomized, placebo-controlled trial of mixed amphetamine salts for symptoms of comorbid ADHD in pediatric bipolar disorder after mood stabilization with divalproex sodium.
    Scheffer RE, Kowatch RA, Carmody T, Rush AJ.
    Am J Psychiatry; 2005 Jan 01; 162(1):58-64. PubMed ID: 15625202
    [Abstract] [Full Text] [Related]

  • 17. Can adults with attention-deficit/hyperactivity disorder be distinguished from those with comorbid bipolar disorder? Findings from a sample of clinically referred adults.
    Wilens TE, Biederman J, Wozniak J, Gunawardene S, Wong J, Monuteaux M.
    Biol Psychiatry; 2003 Jul 01; 54(1):1-8. PubMed ID: 12842302
    [Abstract] [Full Text] [Related]

  • 18. Efficacy and safety of mixed amphetamine salts extended release (Adderall XR) in the management of attention-deficit/hyperactivity disorder in adolescent patients: a 4-week, randomized, double-blind, placebo-controlled, parallel-group study.
    Spencer TJ, Wilens TE, Biederman J, Weisler RH, Read SC, Pratt R.
    Clin Ther; 2006 Feb 01; 28(2):266-79. PubMed ID: 16678648
    [Abstract] [Full Text] [Related]

  • 19. Bupropion as an add-on therapy in depressed bipolar disorder type I patients with comorbid cocaine dependence.
    Sepede G, Di lorio G, Lupi M, Sarchione F, Acciavatti T, Fiori F, Santacroce R, Martinotti G, Gambi F, Di Giannantonio M.
    Clin Neuropharmacol; 2014 Feb 01; 37(1):17-21. PubMed ID: 24434527
    [Abstract] [Full Text] [Related]

  • 20. A prospective trial of bupropion SR augmentation of partial and non-responders to serotonergic antidepressants.
    DeBattista C, Solvason HB, Poirier J, Kendrick E, Schatzberg AF.
    J Clin Psychopharmacol; 2003 Feb 01; 23(1):27-30. PubMed ID: 12544372
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.